European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

2-Year U.S. Treasury Note Continuous Contract $102.828-0.066-0.06% 5-Year U.S. Treasury Note Continuous Contract $106.461-0.156-0.15% 10-Year U.S. Treasury Note Continuous Contract $109.000-0.234 ...

Peter joined Alzheimer’s Research UK in 2014 and has overseen the significant growth of our work with individual philanthropists, trusts and foundations. He leads on our fundraising for our strategic ...

Alzheimer’s Research UK has a large number of different grant schemes through which you can apply for funding. All applications must fall within Alzheimer’s Research UK’s remit which covers biomedical ...